Physician Survey

We are conducting a survey as part of a graduate school project focused on Marketing for a newly approved schizophrenia drug, Cobenfy. This research aims to gather valuable insights about perceptions, preferences, and experiences related to mental health treatments. Your participation will significantly contribute to our understanding of how to effectively market this important medication. Thank you for taking the time to share your thoughts!

Question Title

* 1. Information

Name

Position

Years of Experience

Practice Type

Specialization

Question Title

* 2. Which treatment do you generally recommend for managing schizophrenia? (Select all that apply)

Oral antipsychotic medications

Long-acting injectable antipsychotics

Other (please specify)

Question Title

* 3. What are the primary factors that guide your choice of therapy for patients? (Select all that apply)

Effectiveness in symptom control

Safety and side effect profile

Patient’s past response to treatment

Treatment costs

Patient preferences

Question Title

* 4. How would you rate your satisfaction with the effectiveness and safety of the current treatments for schizophrenia?

Very satisfied

Satisfied

Neutral

Dissatisfied

Very dissatisfied

Question Title

* 5. What difficulties do you experience with the available treatments for schizophrenia? (Select all that apply)

Side effects (e.g., weight gain, drowsiness)

Challenges with adherence or compliance

Limited options for treatment-resistant cases

Inadequate symptom control

High treatment costs

Question Title

* 6. How do you usually keep yourself updated on advancements and new treatments for schizophrenia? (Select all that apply)

Reading medical journals

Reviewing clinical trial data

Seeking recommendations from colleagues

Interactions with pharmaceutical representatives

Using online medical resources

Question Title

* 7. Do you believe there are unmet needs or gaps in the current treatment options for schizophrenia that a therapy like Cobenfy could address?

Yes

If yes, please provide details:

Question Title

* 8. How would you assess the unique profile of Cobenfy compared to existing therapies in terms of safety, efficacy, and patient acceptance?

Safety differentiates Cobenfy

efficacy differentiates Cobenfy

Patient acceptance differentiates Cobenfy

Other (please specify)

Physician Survey

Question Title

Question Title

* 1. Information

Question Title

* 2. Which treatment do you generally recommend for managing schizophrenia? (Select all that apply)

Question Title

* 3. What are the primary factors that guide your choice of therapy for patients? (Select all that apply)

Question Title

* 4. How would you rate your satisfaction with the effectiveness and safety of the current treatments for schizophrenia?

Question Title

* 5. What difficulties do you experience with the available treatments for schizophrenia? (Select all that apply)

Question Title

* 6. How do you usually keep yourself updated on advancements and new treatments for schizophrenia? (Select all that apply)

Question Title

* 7. Do you believe there are unmet needs or gaps in the current treatment options for schizophrenia that a therapy like Cobenfy could address?

Question Title

* 8. How would you assess the unique profile of Cobenfy compared to existing therapies in terms of safety, efficacy, and patient acceptance?

Question Title

* 9. What are the main barriers you face in prescribing new treatments, such as Cobenfy, for schizophrenia?